Contents

Research Articles

• Lipoxin A₄ Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma

  By Cindy Barnig, Manuela Cernadas, Stefanie Dutile, Xiaoli Liu, Mark A. Perrella, Shamsah Kazani, Michael E. Wechsler, Elliot Israel, Bruce D. Levy

  Science Translational Medicine27 Feb 2013 : 174ra26 Full AccessRestricted Access

  The pro-resolving mediator lipoxin A₄ regulates natural killer cells and type 2 innate lymphoid cells in severe asthma.

  • Editor's Summary
  • Abstract
  • Full Text
  • PDF

• Transferred WT1-Reactive CD8⁺ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients

  By Aude G. Chapuis, Gunnar B. Ragnarsson, Hieu N. Nguyen, Colette N. Chaney, Jeffrey S. Pufnock, Thomas M. Schmitt, Natalie Duerkopp, Ilana M. Roberts, Galina L. Pogosov, William Y. Ho, Sebastian Ochsenreither, Matthias Wölfl, Merav Bar, Jerald P. Radich, Cassian Yee, Philip D. Greenberg

  Science Translational Medicine27 Feb 2013 : 174ra27 Full AccessRestricted Access

  Donor-derived WT1-specific CD8⁺ T cells transferred after hematopoietic cell transplantation mediate antileukemic activity and can establish persistent responses without toxicity to normal tissues in high-risk leukemia patients.

  • Editor's Summary
  • Abstract
  • Full Text
  • PDF

• Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo

  By Jeffrey A. Mosenson, Andrew Zloza, John D. Nieland, Elizabeth Garrett-Mayer, Jonathan M. Eby, Erica J. Huelsmann, Previn Kumar, Cecele J. Denman, Andrew T. Lacek, Frederick J. Kohlhapp, Ahmad Alamiri, Tasha Hughes, Steven D. Bines, Howard L. Kaufman, Andreas Overbeck, Shikhar Mehrotra, Claudia Hernandez, Michael I. Nishimura, Jose A. Guevara-Patino, I. Caroline Le Poole

  Science Translational Medicine27 Feb 2013 : 174ra28 Full AccessRestricted Access

  Vitiligo can be reversed through immune targeting with mutant heat shock protein 70.

  • Editor's Summary
  • Abstract
  • Full Text
  • PDF